US FDA: $1bn needed to cover 'Cures' costs
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has estimated it would cost about $1bn to cover its costs for implementing the provisions in the 21st Century Cures Act, which the House Energy and Commerce Committee started on 19 May to mark up – the point at which amendments will be added, or not, before a vote is taken on whether to move the bill to the full chamber for consideration1.